108128-12-7 Usage
General Description
Methyl 6-azaindole-3-carboxylate is a chemical compound with the molecular formula C11H9NO2. It is a derivative of indole, a common heterocyclic compound found in many natural products and pharmaceuticals. Methyl 6-azaindole-3-carboxylate is used as a building block in organic synthesis and is commonly employed in the preparation of various pharmaceuticals, agrochemicals, and materials. It possesses unique structural and chemical properties that make it useful in the development of new drugs and materials. Additionally, it is a valuable tool for researchers in organic chemistry and drug discovery due to its versatile reactivity and applications in various chemical transformations. Overall, methyl 6-azaindole-3-carboxylate is an important chemical compound with diverse applications in the field of organic chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 108128-12-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,1,2 and 8 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 108128-12:
(8*1)+(7*0)+(6*8)+(5*1)+(4*2)+(3*8)+(2*1)+(1*2)=97
97 % 10 = 7
So 108128-12-7 is a valid CAS Registry Number.
108128-12-7Relevant articles and documents
[4[4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF
-
Page/Page column 40; 41, (2011/07/09)
The present invention relates herein to compounds and compositions for the treatment and amelioration of inflammatory disease. Specifically the present invention relates to compounds that having a tryptase inhibition activity and the intermediates thereof, pharmaceutical compositions comprising such compounds, and a method of treating subjects suffering from a condition disease or disorder that can be ameliorated by the administration of an inhibitor of tryptase including but not limited to for example asthma and other inflammatory diseases including age-related macular degeneration.
